| 1.73 -0.01 (-0.57%) | 04-22 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.12  |
1-year : | 2.39 |
| Resists | First : | 1.81 |
Second : | 2.04 |
| Pivot price | 1.77 |
|||
| Supports | First : | 1.45 |
Second : | 1.2 |
| MAs | MA(5) : | 1.73 |
MA(20) : | 1.78 |
| MA(100) : | 1.47 |
MA(250) : | 1.28 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 23 |
D(3) : | 22 |
| RSI | RSI(14): 51.6 |
|||
| 52-week | High : | 3.08 | Low : | 0.43 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ EUDA ] has closed above bottom band by 31.4%. Bollinger Bands are 34.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.83 - 1.84 | 1.84 - 1.85 |
| Low: | 1.66 - 1.67 | 1.67 - 1.68 |
| Close: | 1.71 - 1.73 | 1.73 - 1.75 |
EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Mon, 01 Apr 2024
EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Up 12.0% in March - Defense World
Thu, 19 Oct 2023
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - Investing.com India
Thu, 12 Oct 2023
EUDA Health signs LOI for proposed merger with TheoremRx - TipRanks.com - TipRanks
Tue, 14 Mar 2023
Understanding the Latest Consumer Price Index (CPI) Report: February 2023 - Penny Stocks
Sun, 20 Nov 2022
EUDA Health (EUDA) Stock Price, News & Analysis - MarketBeat
Thu, 17 Nov 2022
8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 25 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 71.5 (%) |
| Held by Institutions | 4.3 (%) |
| Shares Short | 38 (K) |
| Shares Short P.Month | 22 (K) |
| EPS | -1.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.24 |
| Profit Margin | 0 % |
| Operating Margin | -174.7 % |
| Return on Assets (ttm) | -180.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -54.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.3 |
| EBITDA (p.s.) | -0.54 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1.36 |
| PEG Ratio | 0 |
| Price to Book value | -7.21 |
| Price to Sales | 5.64 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|